E-LIB Suche - Ergebnisse für: Yukami, Hiroki

1

Phase I dose-escalation study on irinotecan, cisplatin, and..:

Yukami, Hiroki ; Kawakami, Hisato ; Yamaguchi, Toshifumi...
International Journal of Clinical Oncology. 28 (2023) 9 - p. 1176-1182 , 2023

Link: https://doi.org/10.1007/..

2

Molecular residual disease and efficacy of adjuvant chemoth..:

Kotani, Daisuke ; Oki, Eiji ; Nakamura, Yoshiaki...
Nature Medicine. 29 (2023) 1 - p. 127-134 , 2023

Link: https://doi.org/10.1038/..

3

Primary tumor location as a predictor of survival in patien..:

Ito, Takahiko ; Takashima, Atsuo ; Yamazaki, Kentaro...
International Journal of Clinical Oncology. 27 (2022) 9 - p. 1450-1458 , 2022

Link: https://doi.org/10.1007/..

4

DENEB: Development of new criteria for curability after loc..:

Miyo, Masaaki ; Kato, Takeshi ; Nakamura, Yoshiaki...
Cancer Science. 113 (2022) 4 - p. 1531-1534 , 2022

Link: https://doi.org/10.1111/..

5

Mixed Response to Cancer Immunotherapy is Driven by Intratu..:

Morinaga, Takao ; Inozume, Takashi ; Kawazu, Masahito...
Cancer Research Communications. 2 (2022) 7 - p. 739-753 , 2022

Link: https://doi.org/10.1158/..

6

Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Mult..:

Yukami, Hiroki ; Kawazoe, Akihito ; Lin, Yi-Tzu...
Clinical Cancer Research. 28 (2022) 16 - p. 3480-3488 , 2022

Link: https://doi.org/10.1158/..

7

Definitive chemoradiotherapy has comparable survival outcom..:

Sawada, Kentaro ; Kotani, Daisuke ; Yukami, Hiroki...
International Journal of Clinical Oncology. 27 (2022) 8 - p. 1279-1288 , 2022

Link: https://doi.org/10.1007/..

8

Long-term clinical outcomes of patients diagnosed with pT1a..:

Kadota, Tomohiro ; Sato, Daiki ; Inaba, Atsushi...
Esophagus. 19 (2021) 1 - p. 153-162 , 2021

Link: https://doi.org/10.1007/..

9

756 LONG-TERM OUTCOME AFTER ENDOSCOPIC SUBMUCOSAL DISSECTIO..:

Inaba, Atsushi ; Kadota, Tomohiro ; Nishihara, Keiichiro...
Diseases of the Esophagus. 34 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

10

CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive plat..:

Taniguchi, Hiroya ; Nakamura, Yoshiaki ; Kotani, Daisuke...
Cancer Science. 112 (2021) 7 - p. 2915-2920 , 2021

Link: https://doi.org/10.1111/..

11

Impact of modified FOLFOX‐6 for patients with gastric cance..:

Yukami, Hiroki ; Terazawa, Tetsuji ; Goto, Masahiro...
Asia-Pacific Journal of Clinical Oncology. 15 (2018) 5 - p. , 2018

Link: https://doi.org/10.1111/..

12

Molecular residual disease and efficacy of adjuvant chemoth..:

Kotani, Daisuke ; Oki, Eiji ; Nakamura, Yoshiaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873552/. , 2023

Link: http://www.ncbi.nlm.nih...

13

DENEB: Development of new criteria for curability after loc..:

Miyo, Masaaki ; Kato, Takeshi ; Nakamura, Yoshiaki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990725/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Mixed Response to Cancer Immunotherapy is Driven by Intratu..:

Morinaga, Takao ; Inozume, Takashi ; Kawazu, Masahito...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010332/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Updated Efficacy Outcomes of Anti-PD-1 Antibodies plus Mult..:

Yukami, Hiroki ; Kawazoe, Akihito ; Lin, Yi-Tzu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662898/. , 2022

Link: http://www.ncbi.nlm.nih...